{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-015520","form_type":"8-K","ticker":"PVCT","cik":"0000315545","company_name":"PROVECTUS BIOPHARMACEUTICALS, INC.","filed_at":"2025-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.922243+00:00","generated_at":"2026-05-19T03:48:48.362573+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"Provectus provides broad business update at annual meeting; no specific results disclosed","bullets":["Company presented on clinical development, regulatory, discovery, manufacturing, IP, and corporate development.","Presentation slides furnished as exhibit 99.1 to the 8-K filing.","No financial results, clinical data, or guidance changes were included in the filing text."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-015520","json":"https://secwatch.observer/filing/0001641172-25-015520.json","markdown":"https://secwatch.observer/filing/0001641172-25-015520.md","text":"https://secwatch.observer/filing/0001641172-25-015520.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/315545/000164117225015520/0001641172-25-015520-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/315545/000164117225015520/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T03:48:48.362573+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}